X0306 4 2020-10-29 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001691102 Yea Christopher C/O KALVISTA PHARMACEUTICALS, INC 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142 0 1 0 0 Chief Development Officer Common Stock 2020-10-29 4 S 0 5000 17.4788 D 62969 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Benjamin L. Palleiko, Attorney-in-Fact 2020-11-02